↓ Skip to main content

Human haematopoietic stem cells express Oct4 pseudogenes and lack the ability to initiate Oct4 promoter-driven gene expression

Overview of attention for article published in Journal of Negative Results in BioMedicine, March 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#28 of 112)
  • Good Attention Score compared to outputs of the same age (78th percentile)

Mentioned by

blogs
1 blog
reddit
1 Redditor

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
37 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Human haematopoietic stem cells express Oct4 pseudogenes and lack the ability to initiate Oct4 promoter-driven gene expression
Published in
Journal of Negative Results in BioMedicine, March 2010
DOI 10.1186/1477-5751-9-2
Pubmed ID
Authors

Zoe Redshaw, Alastair J Strain

Abstract

The transcription factor Oct4 is well defined as a key regulator of embryonic stem (ES) cell pluripotency. In recent years, the role of Oct4 has purportedly extended to the self renewal and maintenance of multipotency in adult stem cell (ASC) populations. This profile has arisen mainly from reports utilising reverse transcription-polymerase chain reaction (RT-PCR) based methodologies and has since come under scrutiny following the discovery that many developmental genes have multiple pseudogenes associated with them. Six known pseudogenes exist for Oct4, all of which exhibit very high sequence homology (three >97%), and for this reason the generation of artefacts may have contributed to false identification of Oct4 in somatic cell populations. While ASC lack a molecular blueprint of transcription factors proposed to be involved with 'stemness' as described for ES cells, it is not unreasonable to assume that similar gene patterns may exist. The focus of this work was to corroborate reports that Oct4 is involved in the regulation of ASC self-renewal and differentiation, using a combination of methodologies to rule out pseudogene interference. Haematopoietic stem cells (HSC) derived from human umbilical cord blood (UCB) and various differentiated cell lines underwent RT-PCR, product sequencing and transfection studies using an Oct4 promoter-driven reporter. In summary, only the positive control expressed Oct4, with all other cell types expressing a variety of Oct4 pseudogenes. Somatic cells were incapable of utilising an exogenous Oct4 promoter construct, leading to the conclusion that Oct4 does not appear involved in the multipotency of human HSC from UCB.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 5%
Netherlands 1 3%
Ukraine 1 3%
Slovenia 1 3%
Unknown 32 86%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 35%
Researcher 9 24%
Student > Bachelor 4 11%
Student > Postgraduate 3 8%
Professor 2 5%
Other 3 8%
Unknown 3 8%
Readers by discipline Count As %
Agricultural and Biological Sciences 19 51%
Biochemistry, Genetics and Molecular Biology 7 19%
Medicine and Dentistry 2 5%
Computer Science 1 3%
Social Sciences 1 3%
Other 3 8%
Unknown 4 11%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 June 2011.
All research outputs
#4,628,952
of 22,663,150 outputs
Outputs from Journal of Negative Results in BioMedicine
#28
of 112 outputs
Outputs of similar age
#20,095
of 95,407 outputs
Outputs of similar age from Journal of Negative Results in BioMedicine
#1
of 1 outputs
Altmetric has tracked 22,663,150 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 112 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,407 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them